Raziel Therapeutics is a clinical-stage pharmaceutical company
raziel therapeutics has raised €20M across 1 funding round from 1 investor, most recently a Series C round in Oct 2019. Based in Rehovot, Israel; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series C |
| €20M |
| Pontifax |
| View deal → |
